The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer

被引:0
|
作者
Yang, Yong [1 ]
Wang, Yichao [2 ]
Wan, Ziwei [1 ]
Qin, Xiong [1 ]
Zhu, Yuming [1 ]
Sheng, Bingyong [3 ]
Zhao, Xiaogang [1 ]
机构
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western M, Dept Oncol, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
recurrence; lung cancer; outcome; completion pulmonary resection; postrecurrence survival; overall survival; INTERNATIONAL ASSOCIATION; SURVIVAL; THERAPY; REIRRADIATION; RADIOTHERAPY; 2ND-LINE;
D O I
10.3389/fsurg.2022.990282
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundRecurrence is one of the most important challenges to manage lung cancer. Selected patients might be candidates for resection. This study assessed the outcomes and hazard factors of patients after completion of lung resection for recurrence, focusing specifically on postrecurrence survival (PRS) and overall survival (OS) after surgery. MethodsThis retrospective study enrolled 63 patients who underwent complete pulmonary resection for recurrence between January 2015 and December 2018. Inclusion criteria include potentially curative first resection for primary lung cancer, histologically proven recurrent or new malignancy, and complete pathological report after both operations. PRS and OS were assessed and the influence of patient and treatment features on these endpoints was evaluated. ResultsMost of the patients recurred at stage IIIA, and nearly three-fourth received complete pneumonectomy. The overall 2- and 5-year survival rates were 95% and 75%, whereas the overall 2- and 5-year postrecurrence survival rates were 55% and 36%, respectively. No patient died within 30 or 90 days after completion of residual lung resection, and no serious complications occurred during follow-up. Upon selection of clinically important variables by the Cox proportional hazards regression model, the r-stage [hazard ratio (HR), 3.35; 95% CI, 1.11-10.10; P = 0.03] and stage of primary tumor (HR, 6.26; 95% CI, 2.00-19.55; P < 0.01) were hazard factors for PRS and OS respectively. ConclusionsComplete pulmonary resection is an acceptable option in selected patients with recurrent lung cancer after surgery. The patients with r-stage earlier than IIIA may benefit from completion pulmonary resection but not IIIB. Completion pneumonectomy failed to significantly prolong the OS. The OS in the enrolled cases was mainly affected by the p-TNM stage assessed by the first resection for primary lung cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Radiotherapy for Locoregional Recurrent Non-Small Cell Lung Cancer
    Kim, Mi Young
    Lee, Jong-Seok
    Kim, Jae-Sung
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S400 - S401
  • [22] RADIOTHERAPY FOR LOCOREGIONAL RECURRENT NON-SMALL CELL LUNG CANCER
    Kim, J.
    Kim, M.
    Jang, N.
    Lee, J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S95 - S96
  • [23] Management strategies for recurrent non-small cell lung cancer
    Fossella, FV
    Lee, JS
    Hong, WK
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 455 - 462
  • [24] Reirradiation for locoregionally recurrent non-small cell lung cancer
    Vyfhuis, Melissa A. L.
    Rice, Stephanie
    Remick, Jill
    Mossahebi, Sina
    Badiyan, Shahed
    Mohindra, Pranshu
    Simone, Charles B., II
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2522 - S2536
  • [25] Validation of completion lobectomy after wedge resection for ≤20 mm non-small cell lung cancer
    Yoshimura, Ryuichi
    Deguchi, Hiroyuki
    Tomoyasu, Makoto
    Kudo, Satoshi
    Shigeeda, Wataru
    Kaneko, Yuka
    Kanno, Hironaga
    Saito, Hajime
    JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 4388 - 4395
  • [26] Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer
    Collaud, Stephane
    Bongiovanni, Massimo
    Pache, Jean-Claude
    Fioretta, Gerald
    Robert, John H.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (03): : 622 - 626
  • [27] Reirradiation for Locoregionally Recurrent Lung Cancer Outcomes in Small Cell and Non-Small Cell Lung Carcinoma
    Kruser, Tim J.
    McCabe, Bradley P.
    Mehta, Minesh P.
    Khuntia, Deepak
    Campbell, Toby C.
    Geye, Heather M.
    Cannon, George M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 70 - 76
  • [28] Lung cancer • 6:: The case for limited surgical resection in non-small cell lung cancer
    Sugarbaker, DJ
    THORAX, 2003, 58 (07) : 639 - 641
  • [29] Physical Activity patients following lung resection for non-small cell lung cancer
    Yanagita, Yorihide
    Oomagari, Masaki
    Machiguchi, Hikaru
    Ogawa, Takaya
    Arizono, Shinichi
    Kozu, Ryo
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [30] Early outcome of anatomical lung resection for non-small cell lung cancer in the elderly
    Patella, M.
    Tessitore, A.
    Cianfarani, A.
    Minerva, E. M.
    Cafarotti, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (16) : 5129 - 5136